Advanced Search

 

Study ID Status Title Patient Level Data
114011 Completed A Phase I Randomized, Placebo-Controlled, Single-Blind, Multiple-Dose, Dose-Escalation Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers Study Listed on ClinicalStudyDataRequest.com
114041 Completed A Microdose Study to Describe the Intravenous Pharmacokinetics of [14C]-GSK2239633 in Healthy Male Subjects Study Listed on ClinicalStudyDataRequest.com
114043 Active, Not Recruiting Systematic Review and Meta-Analysis of the Impact of Alternative Treatments on Mortality Outcomes in Chronic Obstructive Pulmonary Disease (COPD)
114068 Completed A Single-centre, Randomised, Double-blind, Placebo-controlled, Escalating Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers Study Listed on ClinicalStudyDataRequest.com
114070 Completed A single-blind, placebo-controlled, two part study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of GSK2018682 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114089 Completed A Phase I, Randomized, Placebo-Controlled, Crossover Clinical Trial to Assess the Safety of Oral SRT2104 and its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
114092 Completed A multicenter, open-label, dose ranging study to determine the pharmacokinetics and pharmacodynamics of mepolizumab administered intravenously or subcutaneously to adult asthmatic subjects with elevated blood eosinophil levels Study Listed on ClinicalStudyDataRequest.com
114101 Completed Post-marketing safety study to assess the risk of spontaneous abortions in women exposed to Cervarix in the United Kingdom
114130 Completed A Randomized, Double-Blind, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Sitagliptin in Subjects With Type 2 Diabetes Mellitus With Renal Impairment Study Listed on ClinicalStudyDataRequest.com
114136 Completed A single dose, open label, nonrandomized, study to evaluate the pharmacokinetics and absolute bioavailability of GSK962040 given as an oral dose simultaneously with an intravenous microtracer dose of [14C]-GSK962040 in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
114137 Completed An open label, randomized, up-titration study to assess the effect of urine sample handling procedures on the safety results of urine obtained from healthy subjects receiving repeat doses of ezogabine/retigabine. Study Listed on ClinicalStudyDataRequest.com
114155 Completed An open-label pilot study to evaluate the safety, tolerability,pharmacokinetics, exploratory efficacy and pharmacodynamicsof oral pazopanib administered for 28 days to neovascular age-relatedmacular degeneration patients
114156 Completed A Long-term Study to Evaluate the Safety and Tolerability of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Japanese Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
114161 Completed A Six-Month Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Indian Postmenopausal Women with Osteoporosis
114163 Completed A Six Month Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study with a Six Month Open-Label Extension to Evaluate the Efficacy and Safety of Denosumab in Korean Postmenopausal Women with Osteoporosis
114169 Completed A 24 Week Study to Evaluate the Predictive Ability of the COPD Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients with Chronic Obstructive Pulmonary Disease Study Listed on ClinicalStudyDataRequest.com
114176 Terminated Post-marketing safety study to assess the risk of spontaneous abortion following administration of CERVARIX in the United States and Canada
114179 Completed A Randomized, Open-Label, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide in Subjects With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
114182 Completed Safety and immunogenicity of GSK2186877A candidate seasonal influenza vaccine in healthy children 6 to 35 months of age. Study Listed on ClinicalStudyDataRequest.com
114187 Completed A randomized, single blind, placebo-controlled, three period crossover, dose selection study to evaluate the effect of GSK256073, an HM74A receptor agonist, on glucose and NEFA 24 hour profile in type 2 diabetic patients. Study Listed on ClinicalStudyDataRequest.com
114248 Completed Immunogenicity and safety study of one dose of GSK Biologicals’ meningococcal vaccine GSK 134612 (blinded lots) versus one dose of Mencevax™ ACWY in healthy subjects aged 18-25 years Study Listed on ClinicalStudyDataRequest.com
114249 Completed Immunogenicity and safety study of one dose of GSK Biologicals’ meningococcal vaccine GSK 134612 (blinded lots) versus one dose of Menactra® in healthy subjects aged 10-25 years Study Listed on ClinicalStudyDataRequest.com
114255 Completed A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Five-Treatment, Four 6-Week Period Cross-Over, Multi-Center Study to Evaluate the Effect of Adding GSK2190915 100mg, GSK2190915 300mg, Montelukast 10mg or Placebo Tablets Once Daily or Salmeterol 50mcg Inhalation Powder Twice Daily to Fluticasone Propionate 100mcg Inhalation Powder Twice Daily in Uncontrolled Asthmatic Subjects ≥ 12 Years of Age Study Listed on ClinicalStudyDataRequest.com
114263 Completed A Study of the Efficacy and Safety of Multiple Doses of Dutasteride versus Placebo and Finasteride in the Treatment of Male Subjects with Androgenetic Alopecia Study Listed on ClinicalStudyDataRequest.com
114267 Completed A Phase III randomized, open-label study comparing GSK1120212 to chemotherapy in subjects with advanced or metastatic BRAF V600E/K mutation-positive melanoma

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.